Shili Wan

Title: Shili Wan: Innovator in Histone Acetyltransferase Inhibition

Introduction

Shili Wan is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of biochemistry, particularly in the development of inhibitors for histone acetyltransferases (HATs). His work has implications for the treatment of various diseases related to HAT activity.

Latest Patents

Shili Wan holds a patent for a histone acetyltransferase (HAT) inhibitor. The patent discloses a compound represented by a specific general formula, along with various forms such as pharmaceutically acceptable salts, stereoisomers, and isotope-labeled compounds. This invention includes a preparation method and a pharmaceutical composition that can be used in treating HAT-related diseases or conditions.

Career Highlights

Throughout his career, Shili Wan has worked with esteemed institutions such as the Chinese Academy of Sciences and the Suzhou Institute of Materia Medica. His research has focused on the biochemical mechanisms of histone modification and its therapeutic potential.

Collaborations

Shili Wan has collaborated with notable colleagues, including Bing Zhou and Cheng Luo. Their combined expertise has contributed to advancements in the understanding of histone acetylation and its role in cellular processes.

Conclusion

Shili Wan's innovative work in the field of histone acetyltransferase inhibition showcases his dedication to advancing medical science. His contributions are paving the way for new therapeutic strategies in treating HAT-related diseases.